Perseo pharma AG
About Perseo pharma AG
The startup has developed a drug discovery and delivery platform that utilizes proprietary nanotechnology to create oral enzyme therapies. This technology protects enzymes with a nano-shield and targets them to the mucus of the small intestine, reducing the need for multiple pills in the treatment of digestive diseases.
The startup has developed a drug discovery and delivery platform that utilizes proprietary nanotechnology to create oral enzyme therapies. This technology protects enzymes with a nano-shield and targets them to the mucus of the small intestine, reducing the need for multiple pills in the treatment of digestive diseases.
What does Perseo pharma AG do?
The startup has developed a drug discovery and delivery platform that utilizes proprietary nanotechnology to create oral enzyme therapies. This technology protects enzymes with a nano-shield and targets them to the mucus of the small intestine, reducing the need for multiple pills in the treatment of digestive diseases.
Where is Perseo pharma AG located?
Perseo pharma AG is based in Basel, Switzerland.
When was Perseo pharma AG founded?
Perseo pharma AG was founded in 2019.
How much funding has Perseo pharma AG raised?
Perseo pharma AG has raised 410000.
- Location
- Basel, Switzerland
- Founded
- 2019
- Funding
- 410000
- Employees
- 10 employees